Allworth Financial’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$679 Sell
72
-9
-11% -$99 ﹤0.01% 4667
2025
Q4
$1.01K Sell
81
-46
-36% -$612 ﹤0.01% 4351
2025
Q3
$1.82K Buy
127
+119
+1,488% +$1.63K ﹤0.01% 4050
2025
Q2
$99 Sell
8
-84
-91% -$1.22K ﹤0.01% 4398
2025
Q1
$1.54K Sell
92
-221
-71% -$5.2K ﹤0.01% 3309
2024
Q4
$7.78K Buy
313
+223
+248% +$4.87K ﹤0.01% 2557
2024
Q3
$1.64K Sell
90
-107
-54% -$2.48K ﹤0.01% 3042
2024
Q2
$6.17K Sell
197
-193
-49% -$5.72K ﹤0.01% 2419
2024
Q1
$13.8K Sell
390
-50
-11% -$2K ﹤0.01% 1973
2023
Q4
$19.2K Buy
440
+328
+293% +$12.9K ﹤0.01% 1675
2023
Q3
$4.28K Buy
112
+89
+387% +$3.74K ﹤0.01% 2179
2023
Q2
$946 Buy
+23
New +$1.11K ﹤0.01% 2749
2022
Q3
Sell
-2
Closed 2856
2022
Q2
$0 Sell
2
-3
-60% -$180 ﹤0.01% 2580
2022
Q1
$0 Sell
5
-1
-17% -$66 ﹤0.01% 2235
2021
Q4
$0 Buy
+6
New +$406 ﹤0.01% 2029
2020
Q3
Sell
-187
Closed -$9K 1219
2020
Q2
$9K Hold
187
﹤0.01% 745
2020
Q1
$8K Buy
+187
New +$9.81K ﹤0.01% 751

Other funds holding IART

Allworth Financial's IART Position: Q1 2026 in Review

Allworth Financial reduced its Integra LifeSciences (IART) stake by 11% in Q1 2026, selling an estimated $99 and leaving 72 shares worth $679. The position accounts for ﹤0.01% of the portfolio, ranked #4667.

Allworth Financial first reported a position in IART in Q1 2020 and has held it in 17 quarters since. The position peaked at $19.2K in Q4 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Allworth Financial held 72 shares of Integra LifeSciences worth $679 as of Q1 2026.
  • Allworth Financial sold 9 Integra LifeSciences shares in Q1 2026, an estimated $99.
  • Integra LifeSciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4667 holding.
  • Allworth Financial first reported a position in Integra LifeSciences in Q1 2020 and has held it in 17 quarters since.
  • Allworth Financial's Integra LifeSciences position peaked at $19.2K in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.